Related Experiment Video
Updated: Sep 25, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Congenital Abnormalities in the Infant of a Diabetic Mother
1Department of Neonatology, Memorial Care Miller Children's and Women's Hospital Long Beach, Long Beach, CA.
Insights
Maternal diabetes increases infant risk for congenital abnormalities, despite advances in pregnancy care. Achieving good glycemic control before conception is critical to prevent birth defects in infants of diabetic mothers.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Neonatology
Background:
- Diabetes mellitus is a prevalent chronic disease globally.
- Infants born to mothers with diabetes face a higher risk of congenital abnormalities.
- Despite improved pregnancy care for diabetic women, the risk of birth defects persists.
Purpose of the Study:
- To review congenital anomalies associated with maternal diabetes.
- To highlight the importance of glycemic control in diabetic pregnancies.
- To inform neonatal clinicians about diabetic embryopathy risks.
Main Methods:
- Literature review of studies on maternal diabetes and congenital anomalies.
- Analysis of mechanisms implicated in diabetic teratogenicity.
- Discussion of clinical identification of at-risk infants.
Main Results:
- Maternal diabetes is linked to a spectrum of fetal anomalies affecting multiple organ systems.
- Teratogenic mechanisms of maternal diabetes are complex and multifactorial.
- Good pre-conception glycemic control is essential for risk reduction.
Conclusions:
- Congenital anomalies remain a significant concern for infants of diabetic mothers.
- Early identification and management of diabetic embryopathy are crucial for neonatal clinicians.
- Further research into prevention and treatment strategies is warranted.
Abstract:
Diabetes mellitus is among the most common chronic diseases worldwide. Infants of diabetic mothers are at increased risk of having congenital abnormalities. Tremendous progress has been achieved in the pregnancy care of diabetic women; however, the risk of birth defects associated with maternal diabetes still exists. These anomalies might arise in many organs and systems of the developing fetus. Many mechanisms have been implicated in the teratogenicity of maternal diabetes and it is critical to achieve good glycemic control before conception in women with diabetes. Neonatal clinicians must be able to identify patients at risk and recognize the signs of diabetic embryopathy. This article presents a review of congenital anomalies associated with maternal diabetes.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

